Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
1994 1
1995 1
1996 2
1998 1
1999 3
2000 4
2001 5
2002 5
2003 14
2004 9
2005 3
2006 8
2007 9
2008 6
2009 5
2010 2
2014 2
2015 5
2016 3
2019 2
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

88 results
Results by year
Filters applied: . Clear all
Page 1
Three- versus six-month adjuvant FOLFOX or CAPOX for high-risk stage II and stage III colon cancer patients: the efficacy results of Hellenic Oncology Research Group (HORG) participation to the International Duration Evaluation of Adjuvant Chemotherapy (IDEA) project.
Souglakos J, Boukovinas I, Kakolyris S, Xynogalos S, Ziras N, Athanasiadis A, Androulakis N, Christopoulou A, Vaslamatzis M, Ardavanis A, Emmanouilides C, Bompolaki I, Kourousis C, Makrantonakis P, Christofyllakis C, Athanasiadis E, Kentepozidis N, Karampeazis A, Katopodi U, Anagnosopoulos A, Papadopoulos G, Prinarakis E, Kalisperi A, Mavroudis D, Georgoulias V. Souglakos J, et al. Among authors: emmanouilides c. Ann Oncol. 2019 Aug 1;30(8):1304-1310. doi: 10.1093/annonc/mdz193. Ann Oncol. 2019. PMID: 31228203 Free article.
Randomized controlled trial of yttrium-90-labeled ibritumomab tiuxetan radioimmunotherapy versus rituximab immunotherapy for patients with relapsed or refractory low-grade, follicular, or transformed B-cell non-Hodgkin's lymphoma.
Witzig TE, Gordon LI, Cabanillas F, Czuczman MS, Emmanouilides C, Joyce R, Pohlman BL, Bartlett NL, Wiseman GA, Padre N, Grillo-López AJ, Multani P, White CA. Witzig TE, et al. Among authors: emmanouilides c. J Clin Oncol. 2002 May 15;20(10):2453-63. doi: 10.1200/JCO.2002.11.076. J Clin Oncol. 2002. PMID: 12011122 Clinical Trial.
Biosimilars: Hope and concern.
Emmanouilides CE, Karampola MI, Beredima M. Emmanouilides CE, et al. J Oncol Pharm Pract. 2016 Aug;22(4):618-24. doi: 10.1177/1078155215603232. Epub 2015 Sep 21. J Oncol Pharm Pract. 2016. PMID: 26391898 Review.
Extended resections for the treatment of patients with T4 stage IIIA non-small cell lung cancer (NSCLC) (T4N0-1M0) with or without cardiopulmonary bypass: a 15-year two-center experience.
Filippou D, Kleontas A, Tentzeris V, Emmanouilides C, Tryfon S, Baka S, Filippou I, Papagiannopoulos K. Filippou D, et al. Among authors: emmanouilides c. J Thorac Dis. 2019 Dec;11(12):5489-5501. doi: 10.21037/jtd.2019.11.33. J Thorac Dis. 2019. PMID: 32030268 Free PMC article.
Infections in liver transplant recipients.
Winston DJ, Emmanouilides C, Busuttil RW. Winston DJ, et al. Among authors: emmanouilides c. Clin Infect Dis. 1995 Nov;21(5):1077-89; quiz 1090-1. doi: 10.1093/clinids/21.5.1077. Clin Infect Dis. 1995. PMID: 8589125 Review. No abstract available.
Opportunistic infections in oncologic patients.
Emmanouilides C, Glaspy J. Emmanouilides C, et al. Hematol Oncol Clin North Am. 1996 Aug;10(4):841-60. doi: 10.1016/s0889-8588(05)70372-5. Hematol Oncol Clin North Am. 1996. PMID: 8811305 Review.
Immunotherapeutic and immunoregulatory drugs in haematologic malignancies.
Pangalis GA, Kyrtsonis MC, Vassilakopoulos TP, Dimopoulou MN, Siakantaris MP, Emmanouilides C, Doufexis D, Sahanas S, Kontopidou FN, Kalpadakis C, Angelopoulou MK, Dimitriadou EM, Kokoris SI, Panayiotidis P. Pangalis GA, et al. Among authors: emmanouilides c. Curr Top Med Chem. 2006;6(16):1657-86. doi: 10.2174/156802606778194235. Curr Top Med Chem. 2006. PMID: 17017950 Review.
88 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page